Your browser doesn't support javascript.
loading
Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China.
Li, Jing; Huang, Liang; Ge, Chao; Zhu, Xingwu; Qiu, Maixuan; Chen, Chaopan; Wei, Shaohua; Yan, Yiqun.
Afiliação
  • Li J; Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, People's Republic of China.
  • Huang L; Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Ge C; Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, People's Republic of China.
  • Zhu X; Department of General Surgery, Ningbo Development Zone Hospital, Ningbo, People's Republic of China.
  • Qiu M; Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, People's Republic of China.
  • Chen C; Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, People's Republic of China.
  • Wei S; Department of General Surgery, Ningbo Development Zone Hospital, Ningbo, People's Republic of China.
  • Yan Y; Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
J Hepatocell Carcinoma ; 10: 949-958, 2023.
Article em En | MEDLINE | ID: mdl-37361905

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article